IDEXX LABORATORIES INC (IDXX) Stock Fundamental Analysis
NASDAQ:IDXX • US45168D1046
629.35 USD
+12.15 (+1.97%)
At close: Feb 13, 2026
629.35 USD
0 (0%)
After Hours: 2/13/2026, 8:16:55 PM
IDXX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. IDXX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IDXX is not valued too expensively and it also shows a decent growth rate. These ratings would make IDXX suitable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year IDXX was profitable.
- In the past year IDXX had a positive cash flow from operations.
- IDXX had positive earnings in each of the past 5 years.
- In the past 5 years IDXX always reported a positive cash flow from operatings.
1.2 Ratios
- IDXX's Return On Assets of 30.34% is amongst the best of the industry. IDXX outperforms 100.00% of its industry peers.
- With an excellent Return On Equity value of 65.81%, IDXX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- IDXX has a Return On Invested Capital of 40.35%. This is amongst the best in the industry. IDXX outperforms 100.00% of its industry peers.
- IDXX had an Average Return On Invested Capital over the past 3 years of 37.60%. This is significantly above the industry average of 8.83%.
- The 3 year average ROIC (37.60%) for IDXX is below the current ROIC(40.35%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| ROIC | 40.35% |
ROA(3y)28.17%
ROA(5y)27.96%
ROE(3y)59.52%
ROE(5y)79.62%
ROIC(3y)37.6%
ROIC(5y)38.02%
1.3 Margins
- IDXX has a better Profit Margin (24.65%) than 95.70% of its industry peers.
- In the last couple of years the Profit Margin of IDXX has grown nicely.
- IDXX has a Operating Margin of 31.34%. This is amongst the best in the industry. IDXX outperforms 98.92% of its industry peers.
- In the last couple of years the Operating Margin of IDXX has grown nicely.
- IDXX has a better Gross Margin (61.72%) than 63.98% of its industry peers.
- In the last couple of years the Gross Margin of IDXX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.34% | ||
| PM (TTM) | 24.65% | ||
| GM | 61.72% |
OM growth 3Y5.66%
OM growth 5Y4.24%
PM growth 3Y6.87%
PM growth 5Y2.75%
GM growth 3Y1.26%
GM growth 5Y1.26%
2. Health
2.1 Basic Checks
- IDXX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, IDXX has less shares outstanding
- Compared to 5 years ago, IDXX has less shares outstanding
- The debt/assets ratio for IDXX has been reduced compared to a year ago.
2.2 Solvency
- IDXX has an Altman-Z score of 21.32. This indicates that IDXX is financially healthy and has little risk of bankruptcy at the moment.
- IDXX has a better Altman-Z score (21.32) than 95.70% of its industry peers.
- The Debt to FCF ratio of IDXX is 1.04, which is an excellent value as it means it would take IDXX, only 1.04 years of fcf income to pay off all of its debts.
- IDXX has a better Debt to FCF ratio (1.04) than 90.32% of its industry peers.
- A Debt/Equity ratio of 0.53 indicates that IDXX is somewhat dependend on debt financing.
- IDXX has a Debt to Equity ratio (0.53) which is in line with its industry peers.
- Although IDXX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 1.04 | ||
| Altman-Z | 21.32 |
ROIC/WACC4.17
WACC9.68%
2.3 Liquidity
- IDXX has a Current Ratio of 1.18. This is a normal value and indicates that IDXX is financially healthy and should not expect problems in meeting its short term obligations.
- IDXX's Current ratio of 1.18 is on the low side compared to the rest of the industry. IDXX is outperformed by 81.18% of its industry peers.
- IDXX has a Quick Ratio of 1.18. This is a bad value and indicates that IDXX is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of IDXX (0.87) is worse than 80.11% of its industry peers.
- The current and quick ratio evaluation for IDXX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
- IDXX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.18%, which is quite good.
- The Earnings Per Share has been growing by 14.26% on average over the past years. This is quite good.
- The Revenue has grown by 10.42% in the past year. This is quite good.
- IDXX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.72% yearly.
EPS 1Y (TTM)16.18%
EPS 3Y17.63%
EPS 5Y14.26%
EPS Q2Q%17.56%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y8.52%
Revenue growth 5Y9.72%
Sales Q2Q%14.28%
3.2 Future
- The Earnings Per Share is expected to grow by 13.75% on average over the next years. This is quite good.
- Based on estimates for the next years, IDXX will show a quite strong growth in Revenue. The Revenue will grow by 9.46% on average per year.
EPS Next Y13.36%
EPS Next 2Y13.1%
EPS Next 3Y13.3%
EPS Next 5Y13.75%
Revenue Next Year8.92%
Revenue Next 2Y8.91%
Revenue Next 3Y9.16%
Revenue Next 5Y9.46%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 48.15, which means the current valuation is very expensive for IDXX.
- Based on the Price/Earnings ratio, IDXX is valued a bit cheaper than the industry average as 69.89% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 27.97. IDXX is valued rather expensively when compared to this.
- The Price/Forward Earnings ratio is 42.48, which means the current valuation is very expensive for IDXX.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IDXX indicates a somewhat cheap valuation: IDXX is cheaper than 69.35% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of IDXX to the average of the S&P500 Index (27.96), we can say IDXX is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.15 | ||
| Fwd PE | 42.48 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IDXX indicates a somewhat cheap valuation: IDXX is cheaper than 67.74% of the companies listed in the same industry.
- 73.12% of the companies in the same industry are more expensive than IDXX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.45 | ||
| EV/EBITDA | 34.29 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IDXX does not grow enough to justify the current Price/Earnings ratio.
- IDXX has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as IDXX's earnings are expected to grow with 13.30% in the coming years.
PEG (NY)3.6
PEG (5Y)3.38
EPS Next 2Y13.1%
EPS Next 3Y13.3%
5. Dividend
5.1 Amount
- IDXX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
629.35
+12.15 (+1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-02 2026-02-02/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners94.94%
Inst Owner Change7.25%
Ins Owners0.21%
Ins Owner Change0.64%
Market Cap50.25B
Revenue(TTM)4.30B
Net Income(TTM)1.03B
Analysts80.91
Price Target781.34 (24.15%)
Short Float %2.41%
Short Ratio3.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)6.47%
Max EPS beat(2)7.81%
EPS beat(4)4
Avg EPS beat(4)5.72%
Min EPS beat(4)1.72%
Max EPS beat(4)7.81%
EPS beat(8)8
Avg EPS beat(8)4.83%
EPS beat(12)12
Avg EPS beat(12)4.67%
EPS beat(16)14
Avg EPS beat(16)4.04%
Revenue beat(2)2
Avg Revenue beat(2)1.45%
Min Revenue beat(2)1.03%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.88%
Revenue beat(8)3
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.06%
Revenue beat(16)4
Avg Revenue beat(16)-1.1%
PT rev (1m)-0.28%
PT rev (3m)12.01%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)0.46%
EPS NY rev (1m)0.19%
EPS NY rev (3m)2.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.37%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)1.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.15 | ||
| Fwd PE | 42.48 | ||
| P/S | 12.06 | ||
| P/FCF | 53.45 | ||
| P/OCF | 46.19 | ||
| P/B | 32.19 | ||
| P/tB | 48.66 | ||
| EV/EBITDA | 34.29 |
EPS(TTM)13.07
EY2.08%
EPS(NY)14.82
Fwd EY2.35%
FCF(TTM)11.77
FCFY1.87%
OCF(TTM)13.63
OCFY2.17%
SpS52.19
BVpS19.55
TBVpS12.93
PEG (NY)3.6
PEG (5Y)3.38
Graham Number75.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| ROCE | 61.18% | ||
| ROIC | 40.35% | ||
| ROICexc | 43.87% | ||
| ROICexgc | 56.38% | ||
| OM | 31.34% | ||
| PM (TTM) | 24.65% | ||
| GM | 61.72% | ||
| FCFM | 22.56% |
ROA(3y)28.17%
ROA(5y)27.96%
ROE(3y)59.52%
ROE(5y)79.62%
ROIC(3y)37.6%
ROIC(5y)38.02%
ROICexc(3y)42.72%
ROICexc(5y)42.26%
ROICexgc(3y)50.78%
ROICexgc(5y)53.04%
ROCE(3y)53.41%
ROCE(5y)55.15%
ROICexgc growth 3Y-1.85%
ROICexgc growth 5Y-3.56%
ROICexc growth 3Y7.2%
ROICexc growth 5Y1.43%
OM growth 3Y5.66%
OM growth 5Y4.24%
PM growth 3Y6.87%
PM growth 5Y2.75%
GM growth 3Y1.26%
GM growth 5Y1.26%
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 1.04 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 105.48% | ||
| Cap/Sales | 3.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.23% | ||
| Profit Quality | 91.51% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 21.32 |
F-Score8
WACC9.68%
ROIC/WACC4.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.3%
Cap/Sales(5y)3.67%
Profit Quality(3y)93.71%
Profit Quality(5y)84.62%
High Growth Momentum
Growth
EPS 1Y (TTM)16.18%
EPS 3Y17.63%
EPS 5Y14.26%
EPS Q2Q%17.56%
EPS Next Y13.36%
EPS Next 2Y13.1%
EPS Next 3Y13.3%
EPS Next 5Y13.75%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y8.52%
Revenue growth 5Y9.72%
Sales Q2Q%14.28%
Revenue Next Year8.92%
Revenue Next 2Y8.91%
Revenue Next 3Y9.16%
Revenue Next 5Y9.46%
EBIT growth 1Y17.46%
EBIT growth 3Y14.66%
EBIT growth 5Y14.37%
EBIT Next Year22.21%
EBIT Next 3Y14.34%
EBIT Next 5Y15.18%
FCF growth 1Y18.62%
FCF growth 3Y40.13%
FCF growth 5Y14.37%
OCF growth 1Y18.68%
OCF growth 3Y29.59%
OCF growth 5Y12.77%
IDEXX LABORATORIES INC / IDXX FAQ
What is the ChartMill fundamental rating of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a fundamental rating of 7 / 10 to IDXX.
What is the valuation status of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a valuation rating of 4 / 10 to IDEXX LABORATORIES INC (IDXX). This can be considered as Fairly Valued.
Can you provide the profitability details for IDEXX LABORATORIES INC?
IDEXX LABORATORIES INC (IDXX) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IDEXX LABORATORIES INC (IDXX) stock?
The Price/Earnings (PE) ratio for IDEXX LABORATORIES INC (IDXX) is 48.15 and the Price/Book (PB) ratio is 32.19.
What is the expected EPS growth for IDEXX LABORATORIES INC (IDXX) stock?
The Earnings per Share (EPS) of IDEXX LABORATORIES INC (IDXX) is expected to grow by 13.36% in the next year.